ANAB
Price
$23.57
Change
+$1.53 (+6.94%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
616.52M
46 days until earnings call
KROS
Price
$16.03
Change
+$0.23 (+1.46%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
641.72M
34 days until earnings call
Interact to see
Advertisement

ANAB vs KROS

Header iconANAB vs KROS Comparison
Open Charts ANAB vs KROSBanner chart's image
AnaptysBio
Price$23.57
Change+$1.53 (+6.94%)
Volume$17.09K
Capitalization616.52M
Keros Therapeutics
Price$16.03
Change+$0.23 (+1.46%)
Volume$19.61K
Capitalization641.72M
ANAB vs KROS Comparison Chart in %
Loading...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANAB vs. KROS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a Buy and KROS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (ANAB: $22.04 vs. KROS: $15.80)
Brand notoriety: ANAB and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANAB: 76% vs. KROS: 54%
Market capitalization -- ANAB: $616.52M vs. KROS: $641.72M
ANAB [@Biotechnology] is valued at $616.52M. KROS’s [@Biotechnology] market capitalization is $641.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANAB’s FA Score shows that 0 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • ANAB’s FA Score: 0 green, 5 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, KROS is a better buy in the long-term than ANAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANAB’s TA Score shows that 4 TA indicator(s) are bullish while KROS’s TA Score has 4 bullish TA indicator(s).

  • ANAB’s TA Score: 4 bullish, 4 bearish.
  • KROS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than KROS.

Price Growth

ANAB (@Biotechnology) experienced а +4.55% price change this week, while KROS (@Biotechnology) price change was -1.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 11, 2025.

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($642M) and ANAB($617M) have the same market capitalization . ANAB YTD gains are higher at: 66.465 vs. KROS (-0.190). KROS has higher annual earnings (EBITDA): 25.5M vs. ANAB (-59.63M). KROS has more cash in the bank: 690M vs. ANAB (266M). ANAB has less debt than KROS: ANAB (15.1M) vs KROS (18M). KROS has higher revenues than ANAB: KROS (233M) vs ANAB (123M).
ANABKROSANAB / KROS
Capitalization617M642M96%
EBITDA-59.63M25.5M-234%
Gain YTD66.465-0.190-35,072%
P/E RatioN/A49.38-
Revenue123M233M53%
Total Cash266M690M39%
Total Debt15.1M18M84%
FUNDAMENTALS RATINGS
ANAB: Fundamental Ratings
ANAB
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
70
SEASONALITY SCORE
1..100
12

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANABKROS
RSI
ODDS (%)
Bullish Trend 5 days ago
90%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
82%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLCGX17.84N/A
N/A
VALIC Company I Large Capital Growth
PQCCX9.99N/A
N/A
PGIM Quant Solutions Mid-Cap Index R6
EPDPX12.95-0.04
-0.31%
EuroPac International Dividend Income A
RGGYX27.04-0.18
-0.66%
Victory RS Global Y
TILPX32.23-0.24
-0.74%
Nuveen Large Cap Growth Premier

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with QTTB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
-0.45%
QTTB - ANAB
40%
Loosely correlated
+0.53%
ADCT - ANAB
37%
Loosely correlated
-3.09%
NRIX - ANAB
37%
Loosely correlated
-4.25%
SPRY - ANAB
36%
Loosely correlated
-0.93%
HRMY - ANAB
35%
Loosely correlated
+1.05%
More

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.32%
INO - KROS
52%
Loosely correlated
-3.57%
ANAB - KROS
41%
Loosely correlated
-0.45%
DNLI - KROS
39%
Loosely correlated
-0.37%
XNCR - KROS
38%
Loosely correlated
-1.34%
ALT - KROS
38%
Loosely correlated
N/A
More